Finally, the percentage of IDH mutation in our patient cohort was not well-balanced, the possible reason was that some imaging-typical glioma patients will not be recommended for amino acid tracer PET imaging owing to social-economic reasons. Here, IDH1 is linked to central nervous system cancer.